Filing Flows › Cardiff Oncology (CRDF) › Q1 2026 › vs Q4 2025
Cardiff Oncology (CRDF) Q1 2026 vs Q4 2025 (quarter over quarter)
Cardiff Oncology's revenue fell $202K (-83%) from $243K in Q4 2025 to $41K in Q1 2026.
Cardiff Oncology, Q1 2026: revenue $41K (-62% year over year), net loss $12.3M, operating cash flow −$12.3M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $41K | $243K | −$202K | -83% |
| Other income, net | $505K | $611K | −$106K | -17% |
| Net loss | $12.3M | $7.2M | $5.1M | +71% |
| Costs & expenses | $12.9M | $8.1M | $4.8M | +60% |
| Operating costs | $12.9M | $8.1M | $4.8M | +60% |
| Research & development | $6.8M | $5.1M | $1.7M | +33% |
| SG&A | $6.1M | $3.0M | $3.1M | +105% |
| Operating cash sources | $14.0M | $7.3M | $6.7M | +92% |
| Depreciation | $87K | $88K | −$1K | -1% |
| Share-based compensation | $1.7M | $1.3M | $399K | +32% |
| Cash used in operations | $12.3M | $6.0M | $6.3M | +106% |
| Net loss absorbed | $12.3M | $7.2M | $5.1M | +71% |
| Working capital & other | $1.7M | $100K | $1.6M | 17× |
Questions
How much did Cardiff Oncology's revenue grow quarter over quarter in Q1 2026?
Cardiff Oncology's revenue fell $202K (-83%) from $243K in Q4 2025 to $41K in Q1 2026.